Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events Underwriting Agreement On January 29, 2026, Vaxcyte, Inc. (“ Vaxcyte ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) w
. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 1.1 Underwriting Agreement, dated January 29, 2026 5.1 Opinion of Skadden, Arps, Sl